Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 23608 | 285 | 30.2 | 81% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 545 | 13948 | REBAMIPIDE//GASTRIC MUCOSAL BLOOD FLOW//GASTRIC MUCOSA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | REBAMIPIDE | Author keyword | 138 | 66% | 45% | 127 |
| 2 | CAS 11911 87 6 | Author keyword | 8 | 100% | 2% | 5 |
| 3 | QUALITY OF ULCER HEALING | Author keyword | 2 | 32% | 2% | 6 |
| 4 | DIETHYLDITHIOCARBAMATE INDUCED ANTRAL ULCER | Author keyword | 2 | 67% | 1% | 2 |
| 5 | MODIFIED LANZA SCORE | Author keyword | 2 | 67% | 1% | 2 |
| 6 | MUCOSAL PROTECTIVE DRUG | Author keyword | 2 | 67% | 1% | 2 |
| 7 | ACUTE GASTRIC MUCOSAL LESION | Author keyword | 1 | 31% | 1% | 4 |
| 8 | SPACE ENVIRONM MED | Address | 1 | 19% | 2% | 7 |
| 9 | MITROS | Author keyword | 1 | 100% | 1% | 2 |
| 10 | MUCOPROTECTIVE DRUG | Author keyword | 1 | 50% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | REBAMIPIDE | 138 | 66% | 45% | 127 | Search REBAMIPIDE | Search REBAMIPIDE |
| 2 | CAS 11911 87 6 | 8 | 100% | 2% | 5 | Search CAS+11911+87+6 | Search CAS+11911+87+6 |
| 3 | QUALITY OF ULCER HEALING | 2 | 32% | 2% | 6 | Search QUALITY+OF+ULCER+HEALING | Search QUALITY+OF+ULCER+HEALING |
| 4 | DIETHYLDITHIOCARBAMATE INDUCED ANTRAL ULCER | 2 | 67% | 1% | 2 | Search DIETHYLDITHIOCARBAMATE+INDUCED+ANTRAL+ULCER | Search DIETHYLDITHIOCARBAMATE+INDUCED+ANTRAL+ULCER |
| 5 | MODIFIED LANZA SCORE | 2 | 67% | 1% | 2 | Search MODIFIED+LANZA+SCORE | Search MODIFIED+LANZA+SCORE |
| 6 | MUCOSAL PROTECTIVE DRUG | 2 | 67% | 1% | 2 | Search MUCOSAL+PROTECTIVE+DRUG | Search MUCOSAL+PROTECTIVE+DRUG |
| 7 | ACUTE GASTRIC MUCOSAL LESION | 1 | 31% | 1% | 4 | Search ACUTE+GASTRIC+MUCOSAL+LESION | Search ACUTE+GASTRIC+MUCOSAL+LESION |
| 8 | MITROS | 1 | 100% | 1% | 2 | Search MITROS | Search MITROS |
| 9 | MUCOPROTECTIVE DRUG | 1 | 50% | 1% | 2 | Search MUCOPROTECTIVE+DRUG | Search MUCOPROTECTIVE+DRUG |
| 10 | OPC 12759 | 1 | 100% | 1% | 2 | Search OPC+12759 | Search OPC+12759 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIULCER COMPOUND | 59 | 90% | 9% | 26 |
| 2 | OPC 12759 | 42 | 74% | 11% | 31 |
| 3 | 21H QUINOLINONE DERIVATIVES | 18 | 89% | 3% | 8 |
| 4 | ANTIULCER AGENT | 15 | 39% | 11% | 30 |
| 5 | 2 4 CHLOROBENZOYLAMINO 3 21H QUINOLINON 4 YLPROPIONIC ACID | 11 | 100% | 2% | 6 |
| 6 | ANTIULCER ACTIVE AGENTS | 11 | 78% | 2% | 7 |
| 7 | REBAMIPIDE | 8 | 32% | 8% | 22 |
| 8 | HEALING ACTION | 4 | 75% | 1% | 3 |
| 9 | RAT GASTRIC ULCER | 3 | 100% | 1% | 3 |
| 10 | ULCER HEALING ACTION | 3 | 60% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| 15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications | 2005 | 38 | 51 | 67% |
| Gastric Ulcerogenic and Healing Impairment Actions of Alendronate, A Nitrogen-Containing Bisphosphonate - Prophylactic Effects of Rebamipide | 2011 | 5 | 45 | 27% |
| Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis | 2015 | 0 | 22 | 45% |
| Rebamipide Helps Defend Against Nonsteroidal Anti-Inflammatory Drugs Induced Gastroenteropathy: A Systematic Review and Meta-Analysis | 2013 | 1 | 43 | 37% |
| Global analysis of gene expression in gastric ischemia-reperfusion: A future therapeutic direction for mucosal protective drugs | 2005 | 11 | 32 | 22% |
| Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases | 2011 | 5 | 34 | 9% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SPACE ENVIRONM MED | 1 | 19% | 2.5% | 7 |
| 2 | TOKUSHIMA KAGASUNO 46310 KAWAUCHI CHO | 1 | 50% | 0.7% | 2 |
| 3 | UNIV HOSP KOSHIGAYA | 1 | 40% | 0.7% | 2 |
| 4 | TOKUSHIMA KAGASUNO 46310 | 1 | 33% | 0.7% | 2 |
| 5 | GERIATR MEDMINAMI KU | 1 | 50% | 0.4% | 1 |
| 6 | INTERNAL MEDASAN DIGEST DIS | 1 | 50% | 0.4% | 1 |
| 7 | RADIOREDOX PONSE TEAM | 1 | 50% | 0.4% | 1 |
| 8 | ZHEJIANG HOSP 1 | 0 | 33% | 0.4% | 1 |
| 9 | GATTON PHARM | 0 | 12% | 1.1% | 3 |
| 10 | GASTROENTEROL SECT 111G | 0 | 10% | 1.1% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000215499 | DIAPHRAGM DISEASE//SMALL INTESTINAL INJURY//SMALL INTESTINAL DAMAGE |
| 2 | 0.0000194768 | GERANYLGERANYLACETONE//TEPRENONE//GASTRIC MUCOSAL CELL |
| 3 | 0.0000159863 | GASTROPROTECTION//GASTRIC ULCER//GASTROPROTECTIVE |
| 4 | 0.0000149609 | ULCER HEALING//ACETIC ACID ULCER//GASTRIC ULCER HEALING |
| 5 | 0.0000127627 | CAPSAICIN SENSITIVE SENSORY NEURONS//BIODEF MED//REPROD ENGN |
| 6 | 0.0000099820 | Z 103//CAS 107667 60 7//POLAPREZINC |
| 7 | 0.0000091968 | LAFUTIDINE//CAPSAICIN SENSITIVE SENSORY NEURON//GASTRIC MUCIN BIOSYNTHESIS |
| 8 | 0.0000060653 | CAGA//VACA//HELICOBACTER PYLORI |
| 9 | 0.0000058057 | POLYGLYCOSYLCERAMIDES//SIALIC ACID SPECIFICITY//PHARMACEUT BIOL PHYTOCHEM |
| 10 | 0.0000051194 | ENDOSCOPIC SUBMUCOSAL DISSECTION//ENDOSCOPIC MUCOSAL RESECTION//EARLY GASTRIC CANCER |